Telehealth Fraud and Abuse: Steering Clear of The Next Frontier in F&A, False Claims Act and Qui Tam Enforcement

Roger Cohen
Partner
Goodwin Procter LLP

Marc Goldsand
Partner
Goldsand Friedberg

Brian McEvoy
Partner
Baker & Hostetler LLP
- Examining the DOJ’s and HHS’ heightened scrutiny of telemedicine fraud and current enforcement trends faced by the industry
- The specific arrangements and activities that the OIG shines a spotlight on in their recent Special Fraud Alert on telehealth
- Takeaways from the recent criminal charges and FCA civil settlements arising from the abuse of special telehealth billing rules
- How telemedicine companies and providers should be evaluating their current compliance programs, billing practices, accuracy of their documentation and third-party relationships to best avoid scrutiny and targeting by federal enforcement agencies
- Stark and Anti-Kickback developments and guidelines impacting telehealth providers: counseling companies on how to stay out of the government crosshairs
- Addressing the specific fraud and abuse implications of the DTC Telehealth model